Propel Bio Management, LLC / HTD
Propel Bio Management, LLC’s Corcept Therapeutics Inc Position
Does Propel Bio Management, LLC own Corcept Therapeutics Inc (HTD)? Yes — 147.8K shares worth $6M (+3.80% of its 13F portfolio) as of Q1 2026.
Position Value
$6M
Q1 2026
Shares
147.8K
% of Portfolio
+3.80%
Quarters Held
1
currently held
Position History HTD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 147.8K | $6M | +3.80% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Propel Bio Management, LLC’s full portfolio or all institutional holders of HTD.